Cargando…

Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals

SIMPLE SUMMARY: Oral etoposide (VP16), an inhibitor of topoisomerase-II, has demonstrated clinical activity in metastatic breast cancer (MBC). To our knowledge, oral VP16 combined with trastuzumab (VP16-T) in HER2+ MBC has not been evaluated before. This combination is biologically relevant, as TOP2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chalumeau, Clelia, Carton, Matthieu, Eeckhoutte, Alexandre, Ballet, Stelly, Vincent-Salomon, Anne, Vuagnat, Perrine, Bellesoeur, Audrey, Pierga, Jean-Yves, Stern, Marc-Henri, Bidard, Francois-Clement, Lerebours, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101021/ https://www.ncbi.nlm.nih.gov/pubmed/35565244 http://dx.doi.org/10.3390/cancers14092114

Ejemplares similares

COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
por: Vuagnat, Perrine, et al.
Publicado: (2020)

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer
por: Porte, B., et al.
Publicado: (2020)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy, Anne-Sophie, et al.
Publicado: (2018)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy-Petit, Anne-Sophie, et al.
Publicado: (2016)

Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy
por: Cabel, Luc, et al.
Publicado: (2020)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues
por: Vincent-Salomon, A, et al.
Publicado: (2008)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
por: Lerebours, Florence, et al.
Publicado: (2021)

Marie Curie
Publicado: (1976)

Madame Curie
por: Eve, Curie
Publicado: (1942)

Madame Curie
Publicado: (1935)

Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort
por: Moinard-Butot, Fabien, et al.
Publicado: (2022)

ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing
por: Eeckhoutte, Alexandre, et al.
Publicado: (2020)

Tribute to Marie Curie
Publicado: (1967)

Irène Joliot-Curie
por: Loriot, Noëlle
Publicado: (1991)

Frédéric Joliot-Curie
por: Pinault, Michel
Publicado: (2000)

Germline MBD4 Mutations and Predisposition to Uveal Melanoma
por: Derrien, Anne-Céline, et al.
Publicado: (2020)

HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
por: Nanou, Afroditi, et al.
Publicado: (2020)

Deciphering HER2-HER3 Dimerization at the Single CTC Level: A Microfluidic Approach
por: Tulukcuoglu Guneri, Ezgi, et al.
Publicado: (2022)

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study
por: Bidard, François-Clément, et al.
Publicado: (2013)

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
por: Cizkova, M, et al.
Publicado: (2013)

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2017)

The Marie Curie RADSAGA project
por: Bennett, Sophia Elizabeth
Publicado: (2017)

Hommage à Marie Curie
Publicado: (1967)

Curie y la radiactividad
por: Strathern, Paul, 1940-
Publicado: (1999)

Marie Curie Nobel Centenary.
Publicado: (2003)

The life and legacy of Marie Curie.
por: Rockwell, Sara
Publicado: (2003)

Pierre Curie, 1859–1906
por: Mould, R.F.
Publicado: (2007)

Marie Curie: a life
por: Quinn, Susan
Publicado: (1996)

The Marie Curie Fellowship Association
por: Brambilla, Nora
Publicado: (2002)

Marie Curie fellowships 2009
Publicado: (2009)

Autobiographical notes and Pierre Curie
por: Sklodowska-Curie, Marie
Publicado: (2006)

Curie Meitner Lamarr, indivisible
por: CERN. Geneva
Publicado: (2016)

Marie Curie takes to the screen
por: Pacchioni, Giulia
Publicado: (2020)

Effect of Trastuzumab–HER2 Complex Formation on Stress-Induced Modifications in the CDRs of Trastuzumab
por: Spanov, Baubek, et al.
Publicado: (2022)

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer
por: Bertucci, Alexandre, et al.
Publicado: (2020)

CERN Marie Curie fellows interviewed on the occasion of Marie Skłodowska-Curie's 150th birthday
por: Ordan, Julien Marius
Publicado: (2017)

HER2-Positive Breast Cancer Patients with Pre-Treatment Axillary Involvement or Postmenopausal Status Benefit from Neoadjuvant Rather than Adjuvant Chemotherapy Plus Trastuzumab Regimens
por: Laas, Enora, et al.
Publicado: (2021)

Maria Sklodowska-Curie Centenary Lectures - a symposium celebrating the centenary of the birth of Maria Sklodowska-Curie
por: Bohr, Aage Niels, et al.
Publicado: (1968)

Anna Stakia, CERN Marie Curie fellow for the occasion of Marie Skłodowska-Curie's 150th birthday
por: Bennett, Sophia Elizabeth
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p3iuispc3pjp72tr1taf7m8rip